The factor XIa inhibitor asundexian reduced recurrent ischemic stroke without increasing major or minor bleeding in patients ...

A research team has demonstrated that clopidogrel is more effective than aspirin as a long-term antiplatelet therapy in ...

An investigational anti-clotting medication, asundexian, has demonstrated a reduction in the risk of a second ischemic ...

Abbreviated dual antiplatelet therapy after percutaneous coronary intervention using third-generation stents remained ...

Dental extraction is performed frequently and can be accompanied by perioperative or postoperative complications. Bleeding is among the most common and important issues to consider in the ...

PARIS, France—After TAVR, patients prescribed single antiplatelet therapy are less likely to report a major adverse event at 3 months than those on dual antiplatelet therapy, according to results of ...

DALLAS -- Dual antiplatelet therapy (DAPT) proved non-inferior to IV alteplase in Chinese patients with minor non-disabling stroke, a researcher reported. In the ARAMIS trial of patients with acute ...

Analysis of hospital registry data found that people who were hospitalized due to bleeding in the brain and who had taken multiple antiplatelet medications, or medications stronger than aspirin, were ...

Antiplatelet therapy is a key component in the management of many medical diseases to decrease the risk of cardiovascular events.1 Acetylsalicyclic acid (ASA) is the most common antiplatelet agent ...

Treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots. A new study has ...

Dual antiplatelet therapy after heart bypass surgery is not more effective than aspirin alone - and it increases the risk of excessive bleeding. This has now been shown in a study of 2,201 patients at ...

A wide range of interindividual variability in the measured and clinical effects of antiplatelet drugs exists. As patients with less platelet inhibition consistently have increased rates of adverse ...